Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 274, Issue 6 43-6, 1998, Pages

  Giulumian, Ararat D ^a   Pollock, David M ^a   Clarke, Natalie ^a   Fuchs, Leslie C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

A 127722; Coronary small artery; Deoxycorticosterone acetate salt hypertensive rats; Mesenteric small artery; Nitric oxide

Indexed keywords

ATRASENTAN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CORONARY ARTERY DISEASE; HYPERTENSION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0031798782     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.274.6.r1613     Document Type: Article

References (30)

1. Archer, S. L., J. M. C. Huang, H. L. Reeve, V. Hampl, S. Tolarova, E. Michelakis, and E. K. Weir. Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determine their response to nitric oxide and hypoxia. Cire. Res. 78:431-442,1996.
2. Bulpitt, C. J., D. G. Beevers, A. Butler, E. C. Coles, D. Hunt, A. D. Munro-Faure, R. B. Nelson, P. W. O'Riordan, J. C. Petrie, B. Rajagopalan, P. B. Rylance, G. Twallin, S. Webster, and C. T. Dollery. The survival of treated hypertensive patients and their causes of death: a report from the DHSS Hypertensive Care Computing Project (DHCCP). J. Hypertens. 4: 93-99,1986.
3. + channels in mediating heterogeneous microvascular responses to acetylcholine in different vascular beds. J. Pharmacol. Exp. Ther. 282:1473-1479,1997.
4. Day, R., R. Larivière, and E. L. Schiffrin. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am. J. Hypertens. 8:294-300,1995.
5. De Carvalho, M. H. C., D. Nigro, R. Scivoletto, H. V. Barbeiro, M. A. de Oliveira, G. de Nucci, and Z. B. Fortes. Comparison of the effect of endothelin on microvessels and macrovessels in Goldblatt II and deoxycorticosterone acetatesalt hypertensive rats. Hypertension 15, Suppl. I: I-68-I-71, 1990.
6. Deng, L. Y., and E. L. Schiffrin. Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1782-H1787,1992.
7. Fuchs, L. C., D. Nuno, K. G. Lamping, and A. K. Johnson. Characterization of endothelium-dependent vasodilation and vasoconstriction in coronary arteries from spontaneously hypertensive rats. Am. J. Hypertens. 9:475-483,1996.
8. Fujita, K., Y. Matsumura, Y. Miyazaki, M. Takaoka, and S. Morimoto. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats. Jpn. J. Pharmacol. 70:313-319,1996.
9. Fukuda, K., A. Baba, M. Kuchii, Y. Nakamura, I. Nishio, and Y. Masuyama. Increased concentration of calcium channel and intracellular free calcium in the acute phase of deoxycorticosterone acetate salt hypertension. J. Hypertens. 6: S261-S263, 1988.
10. Gumkowski, F., G. Kaminska, M. Kaminski, L. W. Morrissey, and R. Auerbach. Heterogeneity of mouse vascular endothelium. In vitro studies of lymphatic, large blood vessels and microvascular endothelial cells. Blood Vessels 24:11-23,1987.
11. Hagen, E. C., and R. C. Webb. Coronary artery reactivity in deoxycorticosterone acetate hypertensive rats. Am. J. Physiol. 247 (Heart Circ. Physiol. 16): H409-H414,1984.
12. Hirata, Y., H. Yoshimi, S. Takata, T. X. Watanabe, S. Kumagai, K. Nakajima, and S. Sakakibara. Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 154:868-875,1988.
13. Julius, S. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 21: 886-893,1993.
14. Larivière, R., R. Day, and E. L. Schiffrin. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive but not spontaneously hypertensive rats. Hypertension 21:294-300,1993.
15. Larivière, R., L. Y. Deng, R. Day, P. Sventek, G. Thibault, and E. L. Schiffrin. Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium of the DOCA-salt hypertensive rat. J. Mol. Cell. Cordial. 27: 2123-2131,1995.
16. Laurant, P., and A. Berthelot. Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium. Br. J. Pharmacol. 119: 1367-1374,1996.
17. Li, J. S., R. Larivière, and E. L. Schiftrin. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 24:183-188,1994.
18. ω-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats. J. Hypertens. 14:1331-1339,1996.
19. Mäkynen, H., P. Arvola, H. Vapaatalo, and I. Pörsti. High calcium diet effectively opposes the development of deoxycorticosterone-salt hypertension in rats. Am. J. Hypertens. 7: 520-528, 1994.
20. Mäkynen, H., M. Kähönen, X. Wu, P. Arvola, and I. Pörsti. Endothelial function in deoxycorticosterone-NaCl hypertension. Circulation 93:1000-1008,1996.
21. Martin, M. J., W. S. Browner, S. B. Hulley, L. H. Kuller, and D. Wentworth. Serum cholesterol, blood pressure and mortality: implications from a cohort of 361,662 men. Lancet 2: 933-936,1986.
22. Nguyen, P. V., A. Parent, L. Y. Deng, J. Flückiger, G. Thibault, and E. L. Schiffrin. Endothelin vascular receptors and responses in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 19: II-98-II-104, 1992.
23. Okada, M., T. Fukuroda, K. Shimamoto, R. Takahashi, F. Ikemoto, M. Yano, and M. Nishikibe. Antihypertensive effects of BQ-123, a selective endothelin ETA receptor antagonist, in spontaneously hypertensive rats treated with DOCA-salt. Eur. J. Pharmacol. 259:339-342,1994.
24. Opgenorth, T. J., A. L. Adler, S. V. Calzadilla, W. J. Chiou, B. D. Dayton, D. B. Dixon, L. J. Gehrke, L. Hernandez, S. R. Magnuson, K. C. Marsh, E. I. Novosad, T. W. Von Geldern, J. L. Wessale, M. Winn, and J. R. Wu-Wong. Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist. J. Pharmacol. Exp. Ther. 276: 473-481,1996.
25. Schiffrin, E. L. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 25:1135-1143,1995.
26. Schiffrin, E. L., L. Y. Deng, and P. Larochelle. Effects of a beta blocker or converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 23:83-91,1994.
27. Schiffrin, E. L., A. Turgeon, and L. Y. Deng. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Br. J. Pharmacol. 121:935-940,1997.
28. Stokes, J., III, W. B. Kannel, P. A. Wolf, R. B. D'Agostino, and L. A. Cupples. Blood pressure as a risk factor for cardiovascular disease. The Framingham study-30 years of follow-up. Hypertension 13:1-13-1-18,1989.
29. White, R. M., C. O. Rivera, and C. B. Davison. Differential contribution of endothelial function to vascular reactivity in conduit and resistance arteries from deoxycorticosterone-salt hypertensive rats. Hypertension 27:1245-1253,1996.
30. A selective endothelin receptor antagonists. 1. Discovery of A-127722. J. Med. Chem. 39: 1039-1048,1996.